HCA Healthcare, Inc. (HCA)

HCA Healthcare Stock Forecast

Stock Price Forecast

The 15 analysts with 12-month price forecasts for HCA Healthcare stock have an average target of 380.2, with a low estimate of 320 and a high estimate of 440. The average target predicts an increase of 22.14% from the current stock price of 311.28.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$320	$380.2	$380	$440
Change	+2.80%	+22.14%	+22.08%	+41.35%

* Price targets were last updated on Jan 27, 2025.

Analyst Ratings

The average analyst rating for HCA Healthcare stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	6	4	3	3	4	4
Buy	6	7	6	6	7	7
Hold	6	6	5	5	4	4
Sell	0	0	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	18	17	15	15	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $405 → $384	Buy	Maintains	$405 → $384	+23.36%	Jan 27, 2025
Kevin Fischbeck B of A Securities	B of A Securities	Strong Buy Maintains $380 → $370	Strong Buy	Maintains	$380 → $370	+18.86%	Jan 27, 2025
Sarah James Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $405	Buy	Reiterates	$405	+30.11%	Jan 27, 2025
Andrew Mok Barclays	Barclays	Buy Maintains $392 → $366	Buy	Maintains	$392 → $366	+17.58%	Jan 27, 2025
Tim Rezvan Keybanc	Keybanc	Buy Maintains $420 → $370	Buy	Maintains	$420 → $370	+18.86%	Jan 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

75.40B

Increased by 6.79%

from 70.60B

Revenue Next Year

79.28B

Increased by 5.16%

from 75.40B

EPS This Year

25.14

Increased by 14.26%

from 22.00

EPS Next Year

28.37

Increased by 12.86%

from 25.14

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	51.53B	58.75B	60.23B	64.97B	70.60B	75.40B	79.28B	83.46B
Revenue Growth	0.38%	14.01%	2.52%	7.86%	8.67%	6.79%	5.16%	5.27%
EPS	10.93	21.16	19.15	18.97	22.00	25.14	28.37	31.66
EPS Growth	8.54%	93.60%	-9.50%	-0.94%	15.97%	14.26%	12.86%	11.59%
Forward PE	-	-	-	-	-	12.38	10.97	9.83
No. Analysts	-	-	-	-	-	26	25	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	79.6B	85.3B	90.2B
Avg	75.4B	79.3B	83.5B
Low	72.3B	75.5B	78.8B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	12.8%	13.2%	13.7%
Avg	6.8%	5.2%	5.3%
Low	2.4%	0.1%	-0.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	26.79	30.84	34.14
Avg	25.14	28.37	31.66
Low	22.94	26.47	29.70

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	21.8%	22.7%	20.3%
Avg	14.3%	12.9%	11.6%
Low	4.3%	5.3%	4.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.